← Back to home

The Immunobiological Technology Institute (bio-manguinhos) / Oswaldo Cruz Foundation (fiocruz)

Clinical trials sponsored by The Immunobiological Technology Institute (bio-manguinhos) / Oswaldo Cruz Foundation (fiocruz), explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Brazil tests homegrown mRNA booster against COVID-19 Results expected Jul 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1

Brazil tests homegrown mRNA booster against COVID-19

Vaccine Not yet recruiting

This early-stage trial tests a new mRNA COVID-19 booster vaccine made by Bio-Manguinhos/Fiocruz. About 90 healthy adults aged 18-59 will receive one of three doses (25, 50, or 100 micrograms) to check safety and immune response. The study is not yet recruiting and will monitor pa…

Phase 1 • Sponsor: The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) • Aim: Vaccine

Last updated Jun 27, 2026 13:06 UTC

The Immunobiological Technology Institute (bio-manguinhos) / Oswaldo Cruz Foundation (fiocruz)

Upcoming readouts

Brazil tests homegrown mRNA booster against COVID-19